Navitus’ 2021 Drug Trend Report Reveals Significant Cost Savings and Improved Member Health

MADISON, Wis., June 16, 2022 – Navitus Health Solutions, an industry-disrupting pharmacy benefit manager (PBM) that’s committed to bringing humanity to pharmacy benefits management, released its 2021 Annual Drug Trend Report demonstrating pharmacy benefit cost savings for its customers and improved affordability for members. Navitus’ new report shows that new clients who moved to Navitus from another PBM in 2021 saved an average of 16%, with additional data on existing clients that savings continued years two through six after implementation.

“At Navitus, we exist to help people access important medication therapies at affordable costs so they can live their fullest lives,” said Brent Eberle, RPh, MBA, Senior Vice President and Chief Pharmacy Officer. “By partnering and aligning with our customers to help them save on pharmacy benefit costs and to improve health outcomes, we work towards our mission of helping humanity.”

The rising costs of medications are a top concern for most Americans. In fact, 30% of adults have not taken their medications as prescribed at least once in the past year because of cost – putting their health and well-being at risk.¹ Navitus’ 100% pass-through, lowest-net-cost philosophy and clinical care programs are designed to achieve greater medication affordability and adherence for members. According to the 2021 Annual Drug Trend Report, commercial plans achieved an all-in, total-net-cost per member per month (PMPM) cost of $84.37 with Navitus, a modest year-over-year increase of 1.5%.²

“Over the last five years, new clients have realized first-year savings ranging from 16% to 25%. Each year, we are delivering more value to plans and their members, and doing the right thing for health care consumers,” said Tom Pabich, Senior Vice President, Business Development & Client Services. “They are also pleased with the outstanding level of customer service as reflected in our superstar Net Promoter Score rating again this year.”

Key highlights from the report reveal:

• Outstanding service- Navitus’ client Net Promoter Score (NPS) increased to 76 from 72 in the prior year.
• Stellar implementation – Navitus clients reported 100% satisfied post implementation.3
• Well-controlled drug spend:
• The dataset revealed non-specialty drug trend of -0.9% in 2021, reflecting how unit cost reduction offset increased utilization.
• Lower specialty unit cost, keeping specialty trend to 4.3%, the lowest in recent years.

To access the full 2021 Navitus Drug Trend Report, download a copy here.

¹ Public Opinion on Prescription Drugs and Their Prices. Kaiser Family Foundation. Published April 5, 2022. Accessed May 4, 2022. https://www.kff.org/health-costs/poll-finding/public-opinion-on-prescription-drugs-and-their-prices/
² All-in, net-cost PMPM was calculated from Navitus commercial clients, including employers of all types (retail, manufacturing, government, school districts) and commercial health plans, and comprised of different and varied health populations.
³ Navitus 2021 implementation satisfaction survey.

More About BRENT EBERLE

As Senior Vice President, Chief Pharmacy Officer, Brent oversees Navitus’ health strategies division, which is responsible for clinical and population health initiatives, drug utilization review programs, formulary and rebate management, and specialty pharmacy operations.

More About Tom pabich

As Senior Vice President of Business Development and Client Services, Tom is responsible for business growth, strategy, account management, best-in-class implementation and exceptional client retention and satisfaction. Using a proven consultative service approach to maximize client satisfaction and deliver real value, he ensures Navitus’ performance aligns with each plan sponsor’s business objectives and the best interests of their members. Under his leadership, the client services team delivers unparalleled service to over 650 clients across multiple lines of business, including state and local government entities, employer/TPA groups and health plans/health systems.